Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100

This study has been completed.
Information provided by (Responsible Party):
Horizon Pharma Ireland, Ltd., Dublin Ireland Identifier:
First received: May 31, 2010
Last updated: June 8, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)